Month: October 2020

The main method of pathogenetic therapy and prevention of thromboembolism in thrombophilia is AT III replacement. If the patient has already received intensive heparin therapy, which is ineffective due to a deficiency of AT III,

What is Partial Red Cell Aplasia? Partial red cell aplasia (PRCA) is a syndrome with a sharp suppression of red blood cell production, isolated normochromic anemia, and deep reticulocytopenia. For the first time, PRCA described